Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Current Liabilities (2016 - 2025)

AC Immune (ACIU) has disclosed Total Current Liabilities for 10 consecutive years, with $118.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 2.93% to $118.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $118.5 million through Dec 2025, up 2.93% year-over-year, with the annual reading at $118.5 million for FY2025, 2.93% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $118.5 million at AC Immune, up from $115.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $118.5 million in Q4 2025, with the low at $11.9 million in Q4 2022.
  • Average Total Current Liabilities over 5 years is $56.5 million, with a median of $21.7 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities plummeted 45.13% in 2022, then surged 652.1% in 2024.
  • Over 5 years, Total Current Liabilities stood at $21.7 million in 2021, then tumbled by 45.13% to $11.9 million in 2022, then grew by 28.42% to $15.3 million in 2023, then soared by 652.1% to $115.1 million in 2024, then rose by 2.93% to $118.5 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $118.5 million, $115.1 million, and $15.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.